Prothena | PRTA - Ebit

Prezzo Delle Azioni
11.10
Cambio Giornaliero
-0.09 -0.80%
Mensile
10.56%
Annuale
51.02%
Q2 Previsione
10.32




Ebit Cambiamento Data
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Akebia Therapeutics USD -5.45M 9.4M 2025-12
ALKERMES USD -48.28M 37.33M 2026-03
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amgen USD 3.83B 130M 2026-03
Biogen USD 514.3M 502.8M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Exelixis USD 251.34M 15.43M 2026-03
Immunic USD -23.33M 2.67M 2025-12
Incyte USD 344.17M 39.71M 2026-03
Ionis Pharmaceuticals USD -118M 97M 2026-03
MacroGenics USD -12.1M 32.26M 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Prothena USD -27.21M 12.55M 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03
Xoma USD -10.08M 4.4M 2024-06